Global Health Partnerships

This book explores the current status and future growth of the global pharmaceutical industry.

Global Health, Pharmaceutical Industry and BRIC explores the status and future growth of the global pharmaceutical industry and the changing needs of global health. Brazil, Russia, and China combined will be the largest pharmaceutical producer and has the largest pharmaceutical market potential in the world. This book fulfiles the need for a comprehensive book on the role of the global pharmecutical industry in general, and the participation of BRIC in specific to address global health needs.

MEI LING WANG is Associate Professor of Social Sciences and Health Policy at the University of the Sciences in Philidelphia, USA. She studied at the Harvard School of Public Health and has devoted her career to writing on global issues.
SHUO ZHANG works for DSS VHA, in Texas, USA and has been at the frontline of China’s health system.
XIAO-WAN WANG is Professor of Health Economics at the school of Public Health, Central South University, China. He has first hand experience of working in China’s health system as an academic and policy analyst.